used a 36-marker CyTOF panel for the immunophenotyping of treatment-naive patients with early ACPA+ (anti-citrullinated protein antibodies) and ACPA-RA and found a reduced frequency of CD62L+ basophils in patients with ACPA-RA (23). The gene discussed is PRTN3; the disease is rheumatoid arthritis.